Results 91 to 100 of about 1,493,150 (189)

Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy

open access: yesPharmaceutics, 2019
Japanese cedar pollinosis is a type I allergic disease and has already become a major public health problem in Japan. Conventional subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) cannot meet patients’ needs owing to the side ...
Qingliang Kong   +8 more
doaj   +1 more source

Clinical aspects of Japanese cedar pollinosis

open access: yesAllergology International, 1998
Japanese cedar pollinosis (JCPsis) is a major national health problem in Japan. The present review provides an update on information on JCPsis based on clinical data from our research group, through the support of the Department of Health and Welfare ...
Minoru Okuda, Takao Shida
doaj   +1 more source

Safety evaluation of the food enzyme endo‐polygalacturonase from the non‐genetically modified Rhizopus oryzae strain MC3‐3‐9 [PDF]

open access: yesEFSA J
Abstract The food enzyme endo‐polygalacturonase (1,4‐α‐D‐galacturonan glycanohydrolase, EC 3.2.1.15) is produced with the non‐genetically modified Rhizopus oryzae strain MC3‐3‐9 by Shin Nihon Chemical Co., Ltd. The food enzyme was considered free from viable cells of the production organism.
EFSA Panel on Food Enzymes (FEZ)   +19 more
europepmc   +2 more sources

Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy

open access: yesAllergology International, 2015
The high prevalence of Japanese cedar pollinosis in Japan is associated with a negative impact on the quality of life of patients, as well as significant loss of productivity among the workforce in early spring, thus representing a serious social problem.
Takashi Fujimura, Seiji Kawamoto
doaj   +1 more source

Stereomicrographs of male strobili of Japanese cedar treated with Sydowia japonica.

open access: yes, 2013
A. Treated Japanese cedar male strobili, about four months after treatment (middle of March, 2012) (bar = 5 mm). B. Hyphae under a microsporophyll (arrow), about four months after treatment (bar = 100 µm). C.
Shigehiro Yamamoto (410933)   +8 more
core   +1 more source

Emerging Risk: Intranasal Tin Exacerbates Allergic Rhinitis in Humans and Mice

open access: yes
Allergy, Volume 81, Issue 7, Page 2515-2518, July 2026.
Delgama A. S. M. Nishadhi   +9 more
wiley   +1 more source

Are Respiratory Viruses Involved in Preseasonal Symptoms or Severity in Japanese Cedar Pollinosis?

open access: yesAllergy & Rhinology, 2016
Background Respiratory virus infections are involved in asthma exacerbations. However, there are no reports of the relationship between respiratory virus infections and Japanese cedar pollinosis.
Hirokuni Otsuka M.D.   +4 more
doaj   +1 more source

Investigation of Cry J1 and Cry J2 Concentrations in Japanese Cedar Pollen and Non-Pollen Seasons. [PDF]

open access: yesIran J Public Health, 2022
Tomizawa H   +4 more
europepmc   +1 more source

Maintenance dose and Japanese cedar pollen-specific immunoglobulin E changes during pediatric Japanese cedar pollen subcutaneous immunotherapy

open access: yesAllergy, Asthma & Clinical Immunology
Abstract The optimal maintenance dose and injection interval for Japanese cedar pollen (JCP) subcutaneous immunotherapy (SCIT) in children remain unclear. In a retrospective cohort of 58 children aged 5 to 15 years who received standardized JCP-SCIT for at least 2 years, we examined associations of maintenance ...
Mayumi Fujita   +3 more
openaire   +1 more source

Elution and adsorptive concentration of Japanese cedar (Cryptomeria japonica) pollen allergen in environmental water

open access: yes, 2005
Elution of Japanese cedar pollen allergens (Cry j I and others) from pollen grains and its adsorptive concentration onto hydrophobic and hydrophilic surfaces were investigated using the surface plasmon resonance technique.
T. Fukuda   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy